Given the critical role of MAPK signaling pathways, such as the classic EGFR/ERK signaling, in PAAD growth and metastasis [18,19], we tested the effect of VPS26A on EGFR/ERK signaling using Western blot. Here, EGFR is linked to pancreatic adenocarcinoma.